- Home
- GROW vs LVTX Comparison
GROW vs LVTX Comparison
Compare GROW & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- LVTX
- Stock Information
- Founded
- GROW 1968
- LVTX 2016
- Country
- GROW United States
- LVTX Netherlands
- Employees
- GROW N/A
- LVTX N/A
- Industry
- GROW Investment Managers
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- LVTX Health Care
- Exchange
- GROW Nasdaq
- LVTX Nasdaq
- Market Cap
- GROW 32.9M
- LVTX 27.9M
- IPO Year
- GROW N/A
- LVTX 2021
- Fundamental
- Price
- GROW $2.44
- LVTX $0.96
- Analyst Decision
- GROW
- LVTX Buy
- Analyst Count
- GROW 0
- LVTX 3
- Target Price
- GROW N/A
- LVTX $3.33
- AVG Volume (30 Days)
- GROW 20.2K
- LVTX 99.7K
- Earning Date
- GROW 02-06-2025
- LVTX 03-19-2025
- Dividend Yield
- GROW 3.69%
- LVTX N/A
- EPS Growth
- GROW N/A
- LVTX N/A
- EPS
- GROW 0.12
- LVTX N/A
- Revenue
- GROW $10,008,000.00
- LVTX $7,345,000.00
- Revenue This Year
- GROW N/A
- LVTX $16.68
- Revenue Next Year
- GROW N/A
- LVTX N/A
- P/E Ratio
- GROW $19.98
- LVTX N/A
- Revenue Growth
- GROW N/A
- LVTX N/A
- 52 Week Low
- GROW $2.38
- LVTX $0.88
- 52 Week High
- GROW $2.95
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- GROW 52.18
- LVTX 37.92
- Support Level
- GROW $2.40
- LVTX $0.92
- Resistance Level
- GROW $2.49
- LVTX $1.01
- Average True Range (ATR)
- GROW 0.04
- LVTX 0.05
- MACD
- GROW 0.00
- LVTX 0.02
- Stochastic Oscillator
- GROW 44.44
- LVTX 25.53
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.